Oppenheimer Equity Research

Analyst Ian Zaffino of Oppenheimer Equity Research maintains his “outperform” rating on Arch Chemicals (NYSE: ARJ). The target price has been raised from $32 to $34. Oppenheimer Equity Research expects ARJ’s core business segments, Personal Care and Industrial Biocides, to deliver healthy...

Analyst Christopher Glynn of Oppenheimer Equity Research has upgraded Acuity Brands Inc (NYSE: AYI) from “perform” to “outperform,” while raising his estimates for the company. The target price has been raised from $37 to $40. According to Oppenheimer Equity Research, AYI’s share price has declined...